Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02855619
Other study ID # CHUBX2015/25
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 15, 2016
Est. completion date March 22, 2020

Study information

Verified date May 2020
Source University Hospital, Bordeaux
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Ventilator-induced diaphragmatic dysfunction appears to contribute to slow weaning from mechanical ventilation. Several trials of inspiratory muscle training to facilitate weaning in intensive care have been performed, with inconsistent results, utilizing different methods of IMT in different populations.

In this study, the investigators want to compare the incidence of 3 inspiratory muscle training programs on inspiratory strength, on difficult to wean patients in intensive care unit.

This is a multi-center randomized trial not blinded with 3 parallels groups:

- Martin's group: a threshold-based IMT is performed like used by Martin in a randomized trial in 2011, in a view of inspiratory strength increase.

- Cader's group: a threshold-based IMT is performed like used by Cader in a randomized trial in 2010 , in a view of inspiratory endurance increase.

- EDRIC's group: a new treshold-based IMT is performed, in a view of both inspiratory strength and endurance increase.

The investigators think that a new threshold-based IMT performed in a view of both inspiratory strength and endurance increase, is more effective and well tolerated than the 2 others protocols.


Description:

The main objective of this study is to determinate which IMT program is the most effective on the inspiratory muscle strength and endurance increase. The investigators will be able to study the impact on the weaning time of IMT performed with the best protocol.

The investigators are going to conduct a randomized trial with intention-to-treat analysis. Following 18h of invasive mechanical ventilation in a controlled mode, the failure of the first single breathe trial of 2 hours and the presence of sevrability criterias defined by the European consensus conference in 2007, 88 participants will be included. Participants will be randomizesd to receive one of the 3 protocols of IMT, 2 times per day, 7 days per week, from the inclusion to the extubation.

The ratio of randomization will be 1:1:2 for a better evaluation of EDRIC's group wich propose a new IMT protocol.


Recruitment information / eligibility

Status Completed
Enrollment 92
Est. completion date March 22, 2020
Est. primary completion date February 22, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patient ventilated more than 18h in a controlled mode;

- First single breathe trial of 2 hours failure;

- Presence of sevrability criterias definied by the European consensus conference in 2007 an usually used:

- diminution of the sedfative agents,

- Patients with spontaneous beath in VAC mode or patient ventilated in a VSAI-PEP mode,

- PaO2/FiO2 =150,

- Absence d'inotropes ou de vasopresseurs à forte dose ou dose croissante (<1mg/h),

- SaO2 > 90% with FiO2 = 50%,

- PEP = 8cmH2O,

- Corporal température between 36°C and 39°C,

- Glasgow Score = 8.

Exclusion Criteria:

- Age < 18 years ;

- medically unstable;

- Poor vital pronostic at very short term;

- Cardiac arrest with a poor neurological prognostic;

- Neuromuscular disease ;

- Pneumothorax non drained ;

- Tracheostomy ;

- Current pregnancy ;

- Patients with guardianship or trusteeship.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Martin
The physiotherapist perform the IMT using the threshold IMT inspiratory muscle trainer, connected to the intubation tube. He manage the resistance to the higher resistance tolerated by the patient in a set of 6 breaths. Participant repeats 4 sets of 6-10 breaths with 2 minutes of resting with mechanical ventilation between each set. This treatment is made twice a day, 7days per week from inclusion to extubation exept if Glasgow score is under 8, hyperthermia more than 39°c, haemodynamic's instability, or hypoxemia( PaO2/FiO2<150).
Cader
The physiotherapist perform the IMT using the threshold IMT inspiratory muscle trainer, connected to the intubation tube. He manage the resistance to 30% of the Maximal Inspiratory Pressure initially recorded the day of the inclusion. Participant breaths against this resistance during 5 minutes. The resistance is daily increased of 10 % to the higher tolerated. This treatment is made twice a day, 7days per week from inclusion to extubation exept if Glasgow score is under 8, hyperthermia more than 39°c, haemodynamic's instability, or hypoxemia( PaO2/FiO2<150).
EDRIC
The physiotherapist perform the IMT using the threshold IMT inspiratory muscle trainer, connected to the intubation tube. He manage the resistance at 30% of the Maximal Inspiratory Pressure of the day for the first set of 20 breaths with a resistance 's increasment of 10% at each set. Participant repeats 4 sets of 20 breaths with 2 minutes of resting with mechanical ventilation between each set. This treatment is made twice a day, 7days per week from inclusion to extubation exept if Glasgow score is under 8, hyperthermia more than 39°c, haemodynamic's instability, or hypoxemia( PaO2/FiO2<150).

Locations

Country Name City State
France Réanimation Médicale Bordeaux
France Réanimation Médicale Lyon

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Bordeaux

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Maximal Inspiratory Pressure score (inspiratory muscle strength index) performed by an external electronic device connected with a unidirectional valve. Baseline and up to day 25
Secondary Peak Pressure (inspiratory muscle endurance index) performed by an incremental threshold test. Baseline and up to day 25
Secondary Duration of the weaning period up to day 25
Secondary ICU lengh of stay Day 30
Secondary Weaning success up to day 27
Secondary Adverse events Day 30
See also
  Status Clinical Trial Phase
Recruiting NCT05012696 - Physiological Effects of Non-invasive Mechanical Ventilation Versus High-flow Nasal Cannula in Critically Ill Patients at High Risk of Extubation Failure N/A
Recruiting NCT04792788 - NAVA vs PSV Ventilation During Weaning From Mechanical Ventilation in Children After Liver Transplantation N/A
Completed NCT03962322 - Diaphragmatic Tissue Doppler During Weaning From Mechanical Ventilation N/A
Completed NCT03140267 - Assessment of Inspiratory Muscles Strength and Endurance Evolution on Difficult to Wean Patients in Intensive Care Unit N/A
Recruiting NCT03018483 - Mechanical Ventilation- Weaning and Thoracic Impedance Tomography N/A
Completed NCT01666054 - Comparison of Weaning on Pressure Support vs. Proportional Assist Ventilation: A Pilot Study N/A
Recruiting NCT06465082 - Diaphragmatic Thickening Fraction as a Predictor of Successful Weaning
Recruiting NCT04779463 - Role of Ultrasound Assessment of Parasternal Intercostal Muscle Thickness During Weaning From Mechanical Ventilation
Recruiting NCT02361021 - Lung Aeration During WEANing From Mechanical Ventilation Determined by Electrical Impedance Tomography and Lung Ultrasound N/A
Completed NCT04227639 - T-piece Versus Pressure-support for the Spontaneous Breathing Trial N/A
Not yet recruiting NCT04224246 - Impact of Gamma-OH on Sleep in ICU Patients Phase 2
Recruiting NCT05000034 - Nurses-driven, Capnography-guided Protocol Weaning From the Mechanical Ventilation at Bedside: A Feasibility Study N/A
Completed NCT01967108 - Post Extubation Chest Physiotherapy in ICU N/A